MPM Oncology Innovations FUND L.P., 10% Owner at Werewolf Therapeutics, Inc. (HOWL), sold 590,086 shares at $1.43 ($783K) on 2025-10-30, disclosed to the SEC on 2025-11-03.
Scheduled sale ($783k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.43 | 86,936 | $124K | 15.9% |
| 2 | $1.43 | 86,936 | $124K | 15.9% |
| 3 | $1.28 | 114,044 | $146K | 18.6% |
| 4 | $1.28 | 114,044 | $146K | 18.6% |
| 5 | $1.29 | 94,063 | $121K | 15.5% |
| 6 | $1.29 | 94,063 |
| $121K |
| 15.5% |
| Total | $1.33 avg | 590,086 | $783K | 100% |